Ann Acad Med Singap
January 2021
(1) Background: Intravitreal anti-vascular endothelial growth factor (anti-VEGF) is an established treatment for center-involving diabetic macular edema (ci-DME). However, the clinical response is heterogeneous. This study investigated miRNAs as a biomarker to predict treatment response to anti-VEGF in DME.
View Article and Find Full Text PDFAim: To present a novel approach to treatment of dural carotid-cavernous fistulas via the medial ophthalmic vein.
Design: Retrospective case series.
Material And Methods: In this retrospective case series, we present 2 patients (3 eyes) with Type C dural CCFs, who had failed cannulation via the conventional transfemoral route and the transorbital superior ophthalmic vein approach.